Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.65 EUR -2.99% Market Closed
Market Cap: 14.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Cash Flow Statement

Cash Flow Statement
Celyad Oncology SA

Rotate your device to view
Cash Flow Statement
Currency: EUR
Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Operating Cash Flow
Net Income
(12)
(56)
(60)
(37)
(35)
(29)
(29)
(17)
(15)
(27)
(26)
(41)
(31)
(8)
(8)
Depreciation & Amortization
1
2
9
1
1
2
2
2
2
2
2
1
1
1
1
Other Non-Cash Items
2
14
9
9
4
(1)
1
(10)
(11)
(3)
(6)
13
13
(1)
0
Change in Working Capital
(3)
(3)
(1)
0
0
(1)
(0)
(2)
(1)
1
(1)
(2)
(4)
(6)
(3)
Cash from Operating Activities
(13)
N/A
(44)
-247%
(44)
+1%
(27)
+38%
(29)
-8%
(28)
+4%
(27)
+5%
(28)
-3%
(25)
+9%
(27)
-6%
(31)
-15%
(28)
+9%
(20)
+28%
(15)
+24%
(10)
+36%
Investing Cash Flow
Capital Expenditures
(0)
(1)
(1)
(2)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
Other Items
(11)
18
40
2
1
10
0
0
0
0
1
7
7
1
0
Cash from Investing Activities
(11)
N/A
18
N/A
39
+121%
1
-98%
(0)
N/A
9
N/A
(0)
N/A
0
N/A
0
-92%
(0)
N/A
1
N/A
7
+550%
7
-2%
0
-94%
(1)
N/A
Financing Cash Flow
Net Issuance of Common Stock
1
1
43
43
0
16
0
0
8
37
29
0
(0)
9
0
Net Issuance of Debt
(0)
(0)
0
0
(0)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
Other
(0)
0
(0)
1
2
3
5
7
4
4
4
4
4
0
2
Cash from Financing Activities
0
N/A
1
+803%
43
+7 029%
44
+2%
1
-97%
18
+1 477%
20
+10%
5
-73%
11
+95%
40
+276%
32
-19%
3
-90%
4
+11%
9
+161%
12
+24%
Change in Cash
Effect of Foreign Exchange Rates
0
1
1
0
(0)
(0)
(0)
0
0
0
0
(0)
0
(0)
0
Net Change in Cash
(23)
N/A
(25)
-7%
39
N/A
17
-56%
(29)
N/A
(1)
+96%
(7)
-480%
(22)
-217%
(15)
+34%
13
N/A
2
-81%
(18)
N/A
(9)
+46%
(5)
+42%
1
N/A
Free Cash Flow
Free Cash Flow
(13)
N/A
(45)
-252%
(45)
+1%
(29)
+36%
(31)
-6%
(29)
+7%
(27)
+5%
(28)
-3%
(26)
+8%
(27)
-5%
(31)
-15%
(28)
+9%
(20)
+27%
(16)
+21%
(10)
+36%

See Also

Discover More